A therapeutic challenge: catastrophic anti-phospholipid syndrome with diffuse alveolar haemorrhage

Immunologic Research

Volumn 62, Issue 2, 2015, Pages 222-224

  Martis, Nihal ^a   Blanchouin, Eléa ^a   Lazdunski, Rémi ^a   Lechtman, Sarah ^a   Robert, Alexandre ^a   Hyvernat, Hervé ^a   Doyen, Denis ^a   Dellamonica, Jean ^a   Bernardin, Gilles ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

Catastrophic anti phospholipid syndrome; Corticosteroids; Diffuse alveolar haemorrhage; Intensive care; Plasma exchange; Rituximab

Indexed keywords

HEPARIN; HYPERTENSIVE FACTOR; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; METHYLPREDNISOLONE; RITUXIMAB; ANTICOAGULANT AGENT; GLUCOCORTICOID; IMMUNOGLOBULIN;

ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIPHOSPHOLIPID SYNDROME; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; BRONCHOSCOPY; CASE REPORT; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSE ALVEOLAR HAEMORRHAGE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; GENERAL CONDITION DETERIORATION; HEART ARREST; HEMOPTYSIS; HUMAN; HYPOXIA; KIDNEY FUNCTION; LETTER; LUNG HEMORRHAGE; LUNG LAVAGE; MIDDLE AGED; PLASMAPHERESIS; PRIORITY JOURNAL; PROPHYLAXIS; RENAL REPLACEMENT THERAPY; RESUSCITATION; STEROID THERAPY; TREATMENT RESPONSE; COMPLICATION; HEMORRHAGE; LUNG DISEASES; PLASMA EXCHANGE; TREATMENT OUTCOME;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; GLUCOCORTICOIDS; HEMORRHAGE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LUNG DISEASES; MIDDLE AGED; PLASMA EXCHANGE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84929709351     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-015-8649-x     Document Type: Letter

References (6)

1. Cartin-Ceba R, Peikert T, Ashrani A, Keogh K, Wylam ME, Ytterberg S, et al. Primary antiphospholipid syndrome-associated diffuse alveolar hemorrhage. Arthritis Care Res (Hoboken). 2014;66:301–10.
2. Berman H, Rodríguez-Pintó I, Cervera R, Morel N, Costedoat-Chalumeau N, Erkan D, et al. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. Autoimmun Rev. 2013;12:1085–90.
3. Cervera R, Rodríguez-Pintó I, Colafrancesco S, Conti F, Valesini G, Rosário C, et al. 14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome. Autoimmun Rev. 2014;13:699–707.
4. Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa M-C, Piette J-C, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12:530–4.
5. Lara AR, Schwarz MI. DIffuse alveolar hemorrhage. Chest. 2010;137:1164–71.
6. Pazzola G, Zuily S, Erkan D. The challenge of bleeding in antiphospholipid antibody-positive patients. Curr Rheumatol Rep. 2015;17:1–11.